EPISODE 052
You can’t be involved in as many successful start-ups as Tom Ressemann and not walk away with great lessons and valuable experiences. The former Entellus founder and CEO examines the wins and challenges and explains how they’re guiding his hand at Amphora Medical.
Podcast Guest
Tom Ressemann
CEO
Amphora Medical
Tom has founded and led companies that have resulted in multi-million dollar exits and an IPO. He has built exceptional leadership teams, growth-minded company cultures and innovative technologies with proven clinical outcomes. Tom serves as a Board Director for Microbiologics, a leader in quality control microorganisms and the urological start-up, Amphora Medical. Tom served as a Board Director for Entellus Medical from 2006 to 2012.
Currently, Tom serves as the President and CEO of Amphora Medical, a leading start-up company developing innovative therapies for urological disorders. From 2006-2010, Tom served as the Founder, President and CEO of Entellus Medical, leading the company through successful commercialization. Entellus Medical (Nasdaq: ENTL) is being acquired by Stryker for $662 Million.
With a commitment to community involvement, learning and development, Tom serves in mentoring roles for young entrepreneurs in the Minneapolis area, donating time and money to help them incubate their ideas and businesses. Tom resides in Minneapolis with his family.
Meet Our Host
Geoff Pardo
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.